The FDA and its Plans to Establish a Presence Overseas
This article was originally published in SRA
Executive Summary
Senior Food and Drug Administration official Murray Lumpkin talks to John Hatjoullis about how the US can no longer consider its borders to be its first line of defence against substandard imports.